Abbvie Endocrine Inc patent expiration
1. Lupron Depot patent expiration
LUPRON DEPOT's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5480656 | ABBVIE ENDOCRINE INC | Prolonged release microcapsules |
Jan, 2013
(11 years ago) | |
| US5643607 | ABBVIE ENDOCRINE INC | Prolonged release microcapsules |
Jan, 2013
(11 years ago) | |
| US5575987 | ABBVIE ENDOCRINE INC | Method of producing sustained-release microcapsules |
Sep, 2013
(11 years ago) | |
| US5716640 | ABBVIE ENDOCRINE INC | Method of producing sustained-release microcapsules |
Sep, 2013
(11 years ago) | |
| US5631020 | ABBVIE ENDOCRINE INC | Method for producing microcapsule |
May, 2014
(10 years ago) | |
| US5631021 | ABBVIE ENDOCRINE INC | Method for producing microcapsule |
May, 2014
(10 years ago) | |
| US6036976 | ABBVIE ENDOCRINE INC | Sustained release microspheres and preparation thereof |
Dec, 2016
(7 years ago) | |
| US7429559 | ABBVIE ENDOCRINE INC | Controlled release composition and method of producing the same |
Dec, 2016
(7 years ago) | |
| US8815801 | ABBVIE ENDOCRINE INC | Controlled release composition and method of producing the same |
Jun, 2022
(2 years ago) | |
| US8921326 | ABBVIE ENDOCRINE INC | Sustained-release composition and method for producing the same |
Feb, 2031
(6 years from now) | |
Drugs and Companies using LEUPROLIDE ACETATE ingredient
Market Authorisation Date: 07 March, 1997
Treatment: Palliative treatment of prostate cancer
Dosage: INJECTABLE
How can I launch a generic of LUPRON DEPOT before it's drug patent expiration?
More Information on Dosage
LUPRON DEPOT family patents
2. Lupron Depot-ped Kit patent expiration
LUPRON DEPOT-PED KIT's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5643607 | ABBVIE ENDOCRINE INC | Prolonged release microcapsules |
Jan, 2013
(11 years ago) | |
| US5480656 | ABBVIE ENDOCRINE INC | Prolonged release microcapsules |
Jan, 2013
(11 years ago) | |
| US5716640 | ABBVIE ENDOCRINE INC | Method of producing sustained-release microcapsules |
Sep, 2013
(11 years ago) | |
| US5575987 | ABBVIE ENDOCRINE INC | Method of producing sustained-release microcapsules |
Sep, 2013
(11 years ago) | |
| US5631020 | ABBVIE ENDOCRINE INC | Method for producing microcapsule |
May, 2014
(10 years ago) | |
| US6036976 | ABBVIE ENDOCRINE INC | Sustained release microspheres and preparation thereof |
Dec, 2016
(7 years ago) | |
| US9617303 | ABBVIE ENDOCRINE INC | Sustained-release composition and method for producing the same |
Mar, 2028
(3 years from now) | |
| US8921326 | ABBVIE ENDOCRINE INC | Sustained-release composition and method for producing the same |
Feb, 2031
(6 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Aug 15, 2014 |
| M(M-107) | Oct 08, 2014 |
| New Strength(NS) | Apr 14, 2026 |
Drugs and Companies using LEUPROLIDE ACETATE ingredient
Market Authorisation Date: 16 April, 1993
Treatment: Treatment of pediatric patients with central precocious puberty
Dosage: POWDER
More Information on Dosage
LUPRON DEPOT-PED KIT family patents